Arkolith/Insider Trading/HRMY/Form 4

Serafin Andrew

CHIEF STRATEGY OFFICERHarmony Biosciences Holdings, Inc. (HRMY) · full profile →Form 4 · filed Jan 28, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 24, 2025Option exercise(M)3K—$03K
Jan 24, 2025Tax withholding(F)865$38.01$33K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 25, 2025Grant(A)37K—$037K
Jan 25, 2025Grant(A)10K—$010K
Jan 24, 2025Option exercise(M)3K—$08K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-002155) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML